癌症患者诊断的途径中的时间间隔
Joseba Rabanales-Sotos1, Ángel López-González1, Blanca Sánchez-Galindo2
1Albacete Nursing School, University of Castilla-La Mancha, 02008 Albacete, Spain.
Nursing reports (Pavia, Italy)
|July 25, 2025
概括
这项研究调查了初级保健中的癌症诊断延迟,分析了患者,全科医生 (GP) 和医疗保健系统因素. 了解这些延迟对于改善及时诊断和治疗癌症至关重要.
科学领域:
- 在瘤学瘤学.
- 主要护理医学 医疗保健
- 医疗保健服务研究 医疗服务研究
背景情况:
- 在发达国家,癌症占死亡人数的很大一部分.
- 初级保健医生往往是癌症症状患者的第一个接触点.
- 诊断延迟可能源于患者,初级保健或医疗保健系统因素.
研究的目的:
- 在初级保健环境中评估癌症患者的诊断延迟.
- 确定导致诊断延迟的患者,医疗保健和疾病相关变量.
- 为促进早期诊断评估和治疗启动的战略提供信息.
主要方法:
- 一项针对癌症患者的回顾性观察性研究.
- 从症状出现到诊断/治疗开始的时间间隔的分析.
- 包括患者,瘤和医疗保健特征作为研究变量.
主要成果:
- 该研究将量化不同间隔的延迟:患者,初级保健,医疗保健系统,诊断和治疗.
- 它将描述从症状出现到诊断和治疗途径的各个阶段所花费的时间.
- 确定影响诊断延迟持续时间的关键因素.
结论:
- 癌症的诊断延迟是多因素的,涉及患者,初级保健和医疗保健系统的要素.
- 了解这些促成因素对于开发缩短诊断间隔的干预措施至关重要.
- 在初级保健中提高诊断过程的效率可以导致更早的癌症检测和改善患者的治疗结果.
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


